Miguel Escalon, M.D., MPH

NPI: 1124256466
Total Payments
$9,354
2024 Payments
$1,451
Companies
8
Transactions
102
Medicare Patients
1,612
Medicare Billing
$627,426

Payment Breakdown by Category

Consulting$4,438 (47.4%)
Food & Beverage$4,124 (44.1%)
Gifts$792.00 (8.5%)

Payments by Nature

Nature of Payment Amount Transactions Share
Consulting Fee $4,438 4 47.4%
Food and Beverage $4,124 94 44.1%
Gift $792.00 4 8.5%

Top Paying Companies

Company Total Records Latest Year
Ipsen Biopharmaceuticals, Inc $3,781 7 $0 (2024)
Merz Pharmaceuticals, LLC $1,693 30 $0 (2024)
Allergan, Inc. $1,281 25 $0 (2022)
Saol Therapeutics Inc. $866.73 5 $0 (2022)
ABBVIE INC. $645.56 16 $0 (2024)
MERZ NORTH AMERICA, INC. $639.47 14 $0 (2020)
Pacira Pharmaceuticals Incorporated $283.15 4 $0 (2024)
Abbott Laboratories $163.89 1 $0 (2017)

Payment History by Year

Year Amount Transactions Top Company
2024 $1,451 28 Merz Pharmaceuticals, LLC ($619.34)
2023 $818.28 20 Merz Pharmaceuticals, LLC ($640.02)
2022 $492.42 10 Merz Pharmaceuticals, LLC ($284.69)
2021 $3,954 9 Ipsen Biopharmaceuticals, Inc ($3,650)
2020 $449.75 7 MERZ NORTH AMERICA, INC. ($319.61)
2019 $1,012 10 Saol Therapeutics Inc. ($660.00)
2018 $207.97 7 Merz North America, Inc. ($108.81)
2017 $967.04 11 Allergan Inc. ($803.15)

All Payment Transactions

102 individual payment records from CMS Open Payments — Page 1 of 5

Date Company Product Nature Form Amount Type
12/11/2024 ABBVIE INC. BOTOX (Biological) Food and Beverage In-kind items and services $34.42 General
Category: BOTOX THERAPEUTIC
11/26/2024 Merz Pharmaceuticals, LLC Xeomin (Biological) Food and Beverage In-kind items and services $17.11 General
Category: Musculoskeletal
11/26/2024 Merz Pharmaceuticals, LLC Xeomin (Biological) Food and Beverage In-kind items and services $3.29 General
Category: Musculoskeletal
11/06/2024 Pacira Pharmaceuticals Incorporated Iovera (Device) Food and Beverage In-kind items and services $124.12 General
Category: Pain Management
10/29/2024 Merz Pharmaceuticals, LLC Xeomin (Biological) Food and Beverage In-kind items and services $103.89 General
Category: Musculoskeletal
09/24/2024 ABBVIE INC. BOTOX (Biological) Food and Beverage In-kind items and services $25.38 General
Category: BOTOX THERAPEUTIC
09/20/2024 Merz Pharmaceuticals, LLC Xeomin (Biological) Food and Beverage In-kind items and services $39.84 General
Category: Musculoskeletal
09/19/2024 Merz Pharmaceuticals, LLC Xeomin (Biological) Food and Beverage In-kind items and services $5.40 General
Category: Musculoskeletal
08/22/2024 Merz Pharmaceuticals, LLC Xeomin (Biological) Food and Beverage In-kind items and services $20.06 General
Category: Musculoskeletal
08/13/2024 Ipsen Biopharmaceuticals, Inc Dysport (Drug) Food and Beverage In-kind items and services $24.12 General
Category: Neurology
07/16/2024 Merz Pharmaceuticals, LLC Xeomin (Biological) Food and Beverage In-kind items and services $87.40 General
Category: Musculoskeletal
07/16/2024 Merz Pharmaceuticals, LLC Xeomin (Biological) Food and Beverage In-kind items and services $25.48 General
Category: Musculoskeletal
07/15/2024 ABBVIE INC. Consulting Fee Cash or cash equivalent $287.50 General
07/13/2024 Pacira Pharmaceuticals Incorporated Iovera (Device) Food and Beverage In-kind items and services $40.96 General
Category: Pain Management
07/11/2024 Ipsen Biopharmaceuticals, Inc Dysport (Drug) Food and Beverage In-kind items and services $25.62 General
Category: Neurology
06/21/2024 Ipsen Biopharmaceuticals, Inc Dysport (Drug) Food and Beverage In-kind items and services $24.82 General
Category: Neurology
06/18/2024 ABBVIE INC. BOTOX (Biological) Food and Beverage In-kind items and services $32.25 General
Category: BOTOX THERAPEUTIC
05/30/2024 Pacira Pharmaceuticals Incorporated Iovera (Device) Food and Beverage In-kind items and services $45.11 General
Category: Pain Management
03/16/2024 Merz Pharmaceuticals, LLC Xeomin (Biological) Food and Beverage In-kind items and services $42.91 General
Category: Musculoskeletal
03/14/2024 Ipsen Biopharmaceuticals, Inc Dysport (Drug) Food and Beverage In-kind items and services $16.34 General
Category: Neurology
03/12/2024 ABBVIE INC. BOTOX (Biological) Food and Beverage In-kind items and services $19.49 General
Category: BOTOX THERAPEUTIC
03/01/2024 Merz Pharmaceuticals, LLC Xeomin (Biological) Food and Beverage In-kind items and services $172.24 General
Category: Musculoskeletal
02/23/2024 Merz Pharmaceuticals, LLC Xeomin (Biological) Food and Beverage In-kind items and services $82.10 General
Category: Musculoskeletal
02/21/2024 Pacira Pharmaceuticals Incorporated Exparel (Drug) Food and Beverage In-kind items and services $72.96 General
Category: Pain Management
02/08/2024 Ipsen Biopharmaceuticals, Inc Dysport (Drug) Food and Beverage In-kind items and services $18.83 General
Category: Neurology

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2023 14 426 21,379 $710,059 $178,471
2022 13 423 23,535 $749,977 $181,412
2021 13 424 18,428 $641,037 $155,814
2020 12 339 13,328 $426,974 $111,729
Total Patients
1,612
Total Services
76,670
Medicare Billing
$627,426
Procedure Codes
52

All Medicare Procedures & Services

52 procedure records from CMS Medicare Utilization — Page 1 of 3

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
J0585 Injection, onabotulinumtoxina, 1 unit Office 2023 21 20,400 $326,400 $101,411 31.1%
99232 Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes Facility 2023 73 463 $138,620 $33,362 24.1%
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2023 61 81 $34,830 $8,349 24.0%
64644 Injection of chemical for paralysis of nerve muscles on arm or leg, 5 or more muscles, first extremity Office 2023 16 35 $24,150 $5,828 24.1%
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2023 47 71 $20,590 $5,201 25.3%
99231 Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes Facility 2023 51 101 $16,160 $4,726 29.2%
64643 Injection of chemical for paralysis of nerve muscles on arm or leg, 1-4 muscles, each additional extremity Office 2023 17 40 $16,000 $3,582 22.4%
76942 Ultrasonic guidance for needle placement Office 2023 29 63 $49,684 $3,444 6.9%
64642 Injection of chemical for paralysis of nerve muscles on arm or leg, 1-4 muscles, first extremity Office 2023 14 25 $40,975 $2,978 7.3%
99223 Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes Facility 2023 18 18 $14,400 $2,675 18.6%
99238 Hospital discharge day management, 30 minutes or less Facility 2023 31 31 $8,990 $2,364 26.3%
99222 Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes Facility 2023 17 18 $9,720 $2,145 22.1%
99239 Hospital discharge day management, more than 30 minutes Facility 2023 15 15 $6,300 $1,548 24.6%
99212 Established patient office or other outpatient visit, 10-19 minutes Office 2023 16 18 $3,240 $857.10 26.5%
J0585 Injection, onabotulinumtoxina, 1 unit Office 2022 25 22,575 $361,200 $107,171 29.7%
99232 Follow-up hospital inpatient care per day, typically 25 minutes Facility 2022 68 425 $127,500 $28,797 22.6%
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2022 66 105 $45,010 $11,206 24.9%
64644 Injection of chemical for paralysis of nerve muscles on arm or leg, 5 or more muscles, first extremity Office 2022 19 32 $22,080 $5,230 23.7%
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2022 50 71 $20,590 $5,223 25.4%
64642 Injection of chemical for paralysis of nerve muscles on arm or leg, 1-4 muscles, first extremity Office 2022 17 31 $50,809 $4,541 8.9%
99231 Follow-up hospital inpatient care per day, typically 15 minutes Facility 2022 45 102 $16,320 $3,739 22.9%
76942 Ultrasonic guidance for needle placement Office 2022 33 75 $56,068 $3,651 6.5%
99223 Initial hospital inpatient care per day, typically 70 minutes Facility 2022 16 18 $14,400 $3,280 22.8%
64643 Injection of chemical for paralysis of nerve muscles on arm or leg, 1-4 muscles, each additional extremity Office 2022 21 33 $13,200 $3,092 23.4%
99222 Initial hospital inpatient care per day, typically 50 minutes Facility 2022 19 22 $11,880 $2,762 23.2%

About Miguel Escalon, M.D., MPH

Miguel Escalon, M.D., MPH is a Physical Medicine & Rehabilitation healthcare provider based in New York, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/25/2009. The National Provider Identifier (NPI) number assigned to this provider is 1124256466.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Miguel Escalon, M.D., MPH has received a total of $9,354 in payments from pharmaceutical and medical device companies, with $1,451 received in 2024. These payments were reported across 102 transactions from 8 companies. The most common payment nature is "Consulting Fee" ($4,438).

As a Medicare-enrolled provider, Escalon has provided services to 1,612 Medicare beneficiaries, totaling 76,670 services with total Medicare billing of $627,426. Data is available for 4 years (2020–2023), covering 52 distinct procedure/service records.

Practice Information

  • Specialty Physical Medicine & Rehabilitation
  • Other Specialties Spinal Cord Injury Medicine
  • Location New York, NY
  • Active Since 06/25/2009
  • Last Updated 10/01/2014
  • Taxonomy Code 208100000X
  • Entity Type Individual
  • NPI Number 1124256466

Products in Payments

  • DYSPORT (Drug) $3,650
  • Xeomin (Biological) $1,693
  • BOTOX (Biological) $1,180
  • Lioresal (baclofen) (Drug) $660.00
  • XEOMIN (Biological) $639.47
  • BOTOX NEURO REHAB (Drug) $294.53
  • Iovera (Device) $210.19
  • DRG leads (Device) $163.89
  • LIORESAL (BACLOFEN) (Drug) $132.00
  • BOTOX (Drug) $131.56
  • Dysport (Drug) $130.73
  • Lioresal Intrathecal (baclofen injection) (Drug) $74.73
  • Exparel (Drug) $72.96
  • BOTOX THERAPEUTIC (Biological) $33.05

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Physical Medicine & Rehabilitation Doctors in New York